Study Shows Newer-Generation Left Ventricular Assist Device Is Associated with Better Outcomes for Heart Failure Patients at 6 Months

Nov 16, 2016

New York

Milscin Hospital Building

A newer generation left ventricular assist device (LVAD) provides better outcomes for patients with advanced heart failure at six months compared to its predecessor, according to a new study. Researchers presented data from the MOMENTUM 3 (Multi-center Study of MagLev Technology in Patients Undergoing MCS Therapy with HeartMate 3) trial at the 2016 Scientific Sessions of the American Heart Association and also co-published in the New England Journal of Medicine.

LVADs are mechanical pumps that are implanted inside a person's chest to help a weakened heart pump blood. Implanting the device can mean the difference between life and death for some open-heart surgery patients or for people waiting for a heart transplant. More than 300,000 U.S. patients each year qualify for some kind of mechanical assist device for heart failure.

“We are constantly striving to improve care for our patients who are experiencing the debilitating effects of advanced heart failure,” said co-first author Dr. Yoshifumi Naka, director of the Cardiac Transplantation and Mechanical Circulatory Support Programs at NewYork-Presbyterian/Columbia University Medical Center. “This trial has shown that we are able to continue to refine and improve technology in mechanical circulatory support and offer patients better outcomes and new hope.”

The HeartMate 3 LVAD features a centrifugal-flow durable left ventricular assist system that utilizes fully magnetically levitated technology designed to lower adverse event rates, especially thrombosis. The miniaturized centrifugal flow device gives it a smaller profile and fewer moving parts than previous generation LVADs, which also helps with ease of surgical placement. The HeartMate II has a different design, composed of an axial continuous-flow pump.

Of the 294 patients involved in the study, 152 were assigned to the centrifugal-flow pump group and 142 to the axial flow pump group. The goal was to evaluate survival free from device replacement and debilitating stroke over a six month time period. At the end of the six-month observation period, there were no significant between-group differences in the rates of death or disabling stroke, but reoperation for pump malfunction was less frequent in the newer generation centrifugal pump group. Suspected or confirmed thrombosis occurred in no patients in the centrifugal-flow pump group, but 14 patients from the axial-flow pump group did experience suspected or confirmed thrombosis.

“Device technology is continuously improving and improvement needs to be proven by research,” said Dr. Naka. “I anticipate there will be new types of devices beyond the HeartMate 3 which enables less invasive or minimally invasive insertion procedure with much lower complication profiles. That’s why it is so important we continue this research.”

The study is titled, “A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure.” The other contributors are: co-first author Mandeep R. Mehra, MD, Nir Uriel, MD, Daniel J. Goldstein, MD, Joseph C. Cleveland, Jr., MD, Paolo C. Colombo, MD, Mary N. Walsh, MD, Carmelo A. Milano, MD, Chetan B. Patel, MD, Ulrich P. Jorde, MD, Francis D. Pagani, MD, Keith D. Aaronson, MD, David A. Dean, MD, Kelly McCants, MD, Akinbobu Itoh, MD, Gregory A. Ewald, MD, Douglas Horstmanshof, MD, James W. Long, MD, and Christoper Salerno, MD for the MOMENTUM 3 Investigators.

The study was sponsored and funded by St. Jude Medical. Dr. Naka is a consultant for St. Jude Medical. See the paper for additional disclosures of conflicts of interest.


NewYork-Presbyterian is one of the nation’s most comprehensive healthcare delivery networks, focused on providing innovative and compassionate care to patients in the New York metropolitan area and around the globe. In collaboration with two renowned medical school partners, Weill Cornell Medicine and Columbia University College of Physicians & Surgeons, NewYork-Presbyterian is consistently recognized as a leader in medical education, groundbreaking research and clinical innovation.

NewYork-Presbyterian has four major divisions: NewYork-Presbyterian Hospital is ranked #1 in the New York metropolitan area by U.S. News and World Report and repeatedly named to the magazine’s Honor Roll of best hospitals in the nation; NewYork-Presbyterian Regional Hospital Network is comprised of leading hospitals in and around New York and delivers high-quality care to patients throughout the region; NewYork-Presbyterian Physician Services connects medical experts with patients in their communities; and NewYork-Presbyterian Community and Population Health features the hospital’s ambulatory care network sites and operations, community care initiatives and healthcare quality programs, including NewYork Quality Care, established by NewYork-Presbyterian, Weill Cornell and Columbia.

NewYork-Presbyterian is one of the largest healthcare providers in the U.S. Each year, nearly 29,000 NewYork-Presbyterian professionals deliver exceptional care to more than 2 million patients.

For more information, visit and find us on Facebook, Twitter and YouTube.

Columbia University Medical Center

Columbia University Medical Center provides international leadership in basic, preclinical, and clinical research; medical and health sciences education; and patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Columbia University Medical Center is home to the largest medical research enterprise in New York City and State and one of the largest faculty medical practices in the Northeast. The campus that Columbia University Medical Center shares with its hospital partner, NewYork-Presbyterian, is now called the Columbia University Irving Medical Center. For more information, visit or

Media Contact:

Jessica Mikulski     212-305-5587     [email protected]

Karin Eskenazi     212-342-0508     [email protected]